[{"Assets_0_Q3_USD":164227000.0,"CommonStockSharesOutstanding_0_Q3_shares":23412754.0,"NetCashProvidedByUsedInOperatingActivities_3_Q3_USD":-24103000.0,"NetIncomeLoss_1_Q3_USD":-9038000.0,"NetIncomeLoss_3_Q3_USD":-36183000.0,"StockholdersEquity_0_Q3_USD":162530000.0,"Ticker":"KRTX","CIK":"1771917","name":"KARUNA THERAPEUTICS, INC.","OfficialName":"Karuna Therapeutics Inc. Common Stock","form":"10-Q","period":"20190930","fy":"2019.0","fp":"Q3","qtrs":"0","uom":"USD","footnote":"nan","Market Cap":"3925750608.0","Country":"United States","Sector":"Health Care","Industry":"Biotechnology: Pharmaceutical Preparations","Market":"NASDAQ","SP500":"nan","filed":"20191107"}]